Clinical Laboratories That Mandate COVID-19 Vaccinations Must Report Adverse Reactions to OSHA
New OSHA regulations treat COVID-19 vaccination adverse reactions as work-related injuries when employers make vaccination mandatory.
Oregon Becomes First State to Make COVID-19 Precaution Rules Permanent
Oregon, one of 28 states that have state Occupational Safety and Health Administration plans, is the first state to step up COVID-19 spread mitigation rules.
COVID-19 Causes Genetic Changes that Create Long-Haul COVID-19 Symptoms, Researchers Find
What Texas researchers found that changed baseline gene expression in airway cells.
FDA and CDC Lift Pause on Johnson & Johnson COVID-19 Vaccine
It remains unclear if this pause will have an effect on people’s perception of the safety of the vaccine and if it will impact vaccination rates.
Six-Foot Rule for Preventing the Spread of COVID-19 is Likely Useless, MIT Researchers Find
Ultimately this research shows that the 6-foot rule should not be a core component of COVID-19 spread mitigation strategies, says MIT professor.
New Updates to FDA Resource Page Provide Valuable Serology Test Information for Clinical Laboratories
What clinical laboratory leaders can expect to find.
FDA Recommends Healthcare Facilities Transition Away from Use of Decontaminated Disposable Respirators
Three new recommendations for respirator supply management.
FDA Issues Amendment to Streamline Authorization Process for Pooled COVID-19 Testing
Streamlining authorizations will allow growth of asymptomatic testing as part of school, workplace, community, and other COVID-19 testing programs.
Long-Haul COVID-19 Emerges as a Concern, Potentially Increasing Need for More COVID-19 Antibody Testing
Clinical laboratories would test for COVID-19 antibodies in those with long-haul COVID-19 symptoms but are unsure if they were ever infected with SARS-CoV-2.
FDA Revokes EUA for a Monoclonal Antibody Treatment, Citing Its Ineffectiveness in Treating SARS-CoV-2 Variants
EUA revocation indicates that SARS-CoV-2 mutations are beginning to impact COVID-19 treatment efficacies.